In your quest to develop effective new therapies for cancer, our clinical trial testing services give you the necessary support to deliver results. We have a long history of success in the enumeration and characterization of rare cells, including Circulating Tumor Cells, Circulating Epithelial Cells, Circulating Melanoma Cells, progenitor cells and more. And Veridex CRS enables you to characterize those cells further, and get high value information at the gene, chromosome and protein levels. From preclinical to Phase 4 trials, we’re the partner you can rely on to move your research forward.
This site is published by Veridex, LLC, which is solely responsible for its contents. © Veridex, LLC 2011. This site is intended for use by residents of the United States of America.
This information is intended for biotech, pharmaceutical, and/or academic researchers. The products/services discussed are for research use only and not for use in diagnostic
procedures. Last updated on: 22 April 2013